Energiekontor AG

  • WKN: 531350
  • ISIN: DE0005313506
  • Land: Deutschland

Nachricht vom 25.10.2021 | 07:30

Energiekontor AG: Release of a capital market information

Energiekontor AG / Announcement pursuant to Article 5 (1b) and (3) of Regulation (EU) No. 596/2014 and Art. 2 (2) and (3) of Commission Delegated Regulation (EU) No. 2016/1052
25.10.2021 / 07:30
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Interim report #22

In the period from 18 October 2021 to 22 October 2021, Energiekontor AG acquired a total of 3,100 shares within the framework of the share buyback announced on 21 May 2021 pursuant to Art. 2 Par. 1 of the delegated Regulation (EU) 2016/1052.

The total number of shares repurchased, the weighted average price and the aggregated volume were as follows for each day of the period mentioned:

Date Total number of shares repurchased (units) Weighted average price (Euro) Aggregate volume (Euro)
10/22/2021 650 74.4923 48,420.00
10/21/2021 550 73.3524 40,343.82
10/20/2021 512 69.0926 35,375.41
10/19/2021 900 70.5967 63,537.03
10/18/2021 488 70.6875 34,495.50
 

The total number of shares bought back under the share buyback programme since 25 May 2021 is 89,023.

The acquisition of the shares of Energiekontor AG was carried out by a credit institution commissioned by Energiekontor AG exclusively via the Frankfurt Stock Exchange (XETRA trading).

Further information on the individual transactions of the share buyback pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No. 596/2014 in conjunction with Art. 2 para. 1, para. 2 and para. 3 of the Delegate Regulation (EU) No. 2016/1052 is available on the Internet at www.energiekontor.de/en/investor-relations/share-buyback

Bremen, 25 October 2021

Energiekontor AG

The Management Board



25.10.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021